Atlas Trials

Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)

Clinical trial NCT02660866 · UNKNOWN

Trial details

NCT number
NCT02660866
Sponsor
North Texas Veterans Healthcare System
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Peripheral Arterial Disease
Start date
2016-07-01
Primary completion
2019-07-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.